58 related articles for article (PubMed ID: 10209855)
1. [Value of clinically established MRI procedures concerning the pretherapeutic evaluation of maximal tumor diameter in primary or recurrent cervix cancer in relation to palpation findings and histopathologic whole mount specimens].
Schäffer U; Hawighorst H; Pilch H; Weikel W; Zuna I; Knapstein PG
Zentralbl Gynakol; 1999; 121(3):131-6. PubMed ID: 10209855
[TBL] [Abstract][Full Text] [Related]
2. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
3. Estimation of tumor volume in cervical cancer by magnetic resonance imaging.
Narayan K; McKenzie A; Fisher R; Susil B; Jobling T; Bernshaw D
Am J Clin Oncol; 2003 Oct; 26(5):e163-8. PubMed ID: 14528092
[TBL] [Abstract][Full Text] [Related]
4. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
Mitchell DG; Snyder B; Coakley F; Reinhold C; Thomas G; Amendola M; Schwartz LH; Woodward P; Pannu H; Hricak H
J Clin Oncol; 2006 Dec; 24(36):5687-94. PubMed ID: 17179104
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension.
deSouza NM; Dina R; McIndoe GA; Soutter WP
Gynecol Oncol; 2006 Jul; 102(1):80-5. PubMed ID: 16427688
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
7. The validity of tumour diameter assessed by magnetic resonance imaging and gross specimen with regard to tumour volume in cervical cancer patients.
Jung DC; Ju W; Choi HJ; Kang S; Park S; Yoo CW; Park SY
Eur J Cancer; 2008 Jul; 44(11):1524-8. PubMed ID: 18573655
[TBL] [Abstract][Full Text] [Related]
8. Cervical carcinoma: assessment of parametrial invasion and lymph node metastasis with magnetic resonance imaging.
Sheu MH; Chang CY; Wang JH; Yen MS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):634-40. PubMed ID: 10969450
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
11. [MRI findings of uterine cervical cancer and value of MRI in preoperative staging].
Li XC; Shang JB; Wu XM; Zeng QS; Sun CP; He JX; Zhong ZW; Chen ZS
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):352-4. PubMed ID: 17425990
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
13. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
[TBL] [Abstract][Full Text] [Related]
14. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
15. [Uterine cervical cancer: usefulness of MR imaging after the initial radiation therapy].
Monzen Y; Mori H; Matsumoto A; Yoshida S; Wakisaka M; Komatsu E; Tashiro M; Hori Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Sep; 55(11):745-50. PubMed ID: 8532506
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management.
Dhoot NM; Kumar V; Shinagare A; Kataki AC; Barmon D; Bhuyan U
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):58-65. PubMed ID: 22339747
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance imaging in the evaluation of parametrial invasion of carcinoma of the cervix uteri: optimization of the study protocol].
Sironi S; Villa G; Rossi S; Bocciolone L; Maggioni A; Sonzogni A; Bellomi M
Radiol Med; 2001 Jun; 101(6):477-84. PubMed ID: 11479445
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
20. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
